{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:42:12Z","timestamp":1792435332137,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaip.2020.10.028","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:38:28Z","timestamp":1603489108000},"page":"760-770.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Caroline","family":"von Spee-Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Echternach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerana","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Gutenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Soetedjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigune","family":"Goldacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Warnatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.10.028_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.anai.2017.01.004","article-title":"Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"118","author":"Hartono","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.10.028_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2020.10.028_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in\u00a0vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib6","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2020.10.028_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2014.04.024","article-title":"Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations","volume":"113","author":"Maglione","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib10","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1183\/09031936.06.00076705","article-title":"Lymphoid interstitial pneumonia: clinical features, associations and prognosis","volume":"28","author":"Cha","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.10.028_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib13","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.10294","article-title":"Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion","volume":"46","author":"Moreland","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2020.10.028_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2172-14-34","article-title":"CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients","volume":"14","author":"Pieper","year":"2013","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","article-title":"Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients","volume":"48","author":"Fernandez-Diaz","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaip.2020.10.028_bib16","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sjogren\u2019s syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2020.10.028_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCG.0b013e3182a4e0ec","article-title":"Abatacept: a new treatment option for refractory adult autoimmune enteropathy","volume":"48","author":"Gupta","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jaip.2020.10.028_bib18","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/art.40165","article-title":"Attenuation of follicular helper T cell-dependent B cell hyperactivity by abatacept treatment in primary Sjogren\u2019s syndrome","volume":"69","author":"Verstappen","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2020.10.028_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaip.2020.10.028_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2020.10.028_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MCP.0000000000000193","article-title":"Clinical trials in pulmonary sarcoidosis","volume":"21","author":"Baughman","year":"2015","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2020.10.028_bib23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.10.028_bib24","series-title":"User\u2019s manual for the 36v2\u00ae Health Survey","author":"Ware","year":"2011"},{"key":"10.1016\/j.jaip.2020.10.028_bib25","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A\u00a0self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2020.10.028_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A\u00a0measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.10.028_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2020.10.028_bib28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00103-013-1700-y","article-title":"Health related quality of life in adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"56","author":"Ellert","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.jaip.2020.10.028_bib29","series-title":"St George\u2019s Respiratory Questionnaire Manual","author":"Jones","year":"2009"},{"key":"10.1016\/j.jaip.2020.10.028_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.10.028_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status: ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaip.2020.10.028_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","article-title":"Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia","volume":"170","author":"Litzman","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.1992.tb06934.x","article-title":"Raised serum neopterin levels in patients with primary hypogammaglobulinaemia: correlation to other immunological parameters and to clinical and histological features","volume":"89","author":"Aukrust","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-11-321695","article-title":"T\u00a0and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency","volume":"118","author":"Ochtrop","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2020.10.028_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1078\/0171-2985-00198","article-title":"Expansion of CD19(hi)CD21(lo\/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia","volume":"206","author":"Warnatz","year":"2002","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaip.2020.10.028_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-019-1992-x","article-title":"Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2020.10.028_bib37","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/ar2984","article-title":"Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment","volume":"12","author":"Simon","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2020.10.028_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2007.083188","article-title":"Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2020.10.028_bib39","first-page":"277","article-title":"Safety of abatacept in Italian patients with rheumatoid arthritis and interstitial lung disease: a multicenter retrospective study","volume":"9","author":"Cassone","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaip.2020.10.028_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib41","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.chest.2019.01.034","article-title":"Rituximab monotherapy for common variable immune deficiency-associated granulomatous-lymphocytic interstitial lung disease","volume":"155","author":"Ng","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.10.028_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.13252","article-title":"Perceived health of patients with common variable immunodeficiency\u2014a cluster analysis","volume":"196","author":"Bayrhuber","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bib43","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a long-term targeted therapy for LRBA deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.10.028_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.1801425","article-title":"Abatacept targets T follicular helper and regulatory T cells, disrupting molecular pathways that regulate their proliferation and maintenance","volume":"202","author":"Glatigny","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2020.10.028_bibE1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2020.10.028_bibE2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1378\/chest.09-2398","article-title":"A\u00a0CT scan score for the assessment of lung disease in children with common variable immunodeficiency disorders","volume":"138","author":"van de Ven","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2020.10.028_bibE3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00103-013-1700-y","article-title":"Health related quality of life in adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"56","author":"Ellert","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.jaip.2020.10.028_bibE4","series-title":"User\u2019s manual for the 36v2\u00ae Health Survey","author":"Ware","year":"2011"},{"key":"10.1016\/j.jaip.2020.10.028_bibE5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.10.028_bibE6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status: ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaip.2020.10.028_bibE7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.10.028_bibE8","series-title":"St George\u2019s Respiratory Questionnaire Manual","author":"Jones","year":"2009"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820311442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:25:51Z","timestamp":1761974751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820311442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213219820311442"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.10.028","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abatacept Use Is Associated with Steroid Dose Reduction and Improvement in Fatigue and CD4-Dysregulation in CVID Patients with Interstitial Lung Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.10.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}